Kenvue misses quarterly estimates as inflation, tariffs squeeze margins

Kenvue reported second-quarter results that fell slightly short of Wall Street expectations, with multiple cost pressures impacting profitability. The consumer-health company’s adjusted gross margin contracted to 60.2% from 60.9% in the year-earlier period, as inflationary pressures, tariff expenses, and currency-related headwinds outpaced gains from supply-chain efficiencies and pricing increases.
The company posted adjusted earnings of 31 cents per share, trailing the analyst consensus